Skip to main content

Table 1 Patient Characteristics

From: Access to pediatric rheumatology care for Juvenile Idiopathic Arthritis in the United Arab Emirates

  Emirati-Emiratis Non-Emirati-Emiratis
Total number 33 33
Female/male 26/7 21/12
Systemic 4 (12.2%) 9 (27.3%)
Persistent Oligo JIA 10 (30.3%) 6 (18.2%)
Extended Oligo JIA 2 (6%) 1 (3%)
Poly JIA RF-ve 10 (30.3%) 10 (30.3%)
Poly JIA RF + ve 7 (21.2%) 5 (15.2%)
Enthesitis-related JIA - 1 (3%)
Psoriatic - 1 (3%)
Mean time from onset to first appointment with Ped Rheum (months) 9 12.4
Range: 1–48 Range: 1–96
Median time from onset to first appointment with Pediatric rheumatology 10 months 14 months
Oral steroids at diagnosis 31 (94%) 32 (97%)
>2 health professionals seen before pediatric rheumatologist 31 (94%) 25 (75.7%)
Referral to ophthalmology prior to pediatric rheumatology 7 (21.2%) 7 (21.2%)
Uveitis 3 (9%) 2 (6%)
MTX alone 10 (30.3%) 5 (15.2%)
Biologic + MTX treatment 10 (30.3%) 15 (45.5%)
Remission on treatment 12 (36.3%) 10 (30.3%)
Disability 1 blind (uveitis) 1 multiple joint deformities
  1. JIA Juvenile Idiopathic Arthritis, MTX Methotrexate